Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 18
1991 44
1992 25
1993 15
1994 18
1995 19
1996 18
1997 16
1998 16
1999 17
2000 14
2001 19
2002 4
2003 7
2004 14
2005 15
2006 17
2007 18
2008 22
2009 19
2010 17
2011 52
2012 52
2013 72
2014 78
2015 261
2016 401
2017 359
2018 315
2019 381
2020 347
2021 311
2022 187
2023 180
2024 186

Search Results

3,132 results

Results by year

Filters applied: . Clear all
Page 1
RAS isoforms and mutations in cancer at a glance.
Hobbs GA, Der CJ, Rossman KL. Hobbs GA, et al. J Cell Sci. 2016 Apr 1;129(7):1287-92. doi: 10.1242/jcs.182873. Epub 2016 Mar 16. J Cell Sci. 2016. PMID: 26985062 Free PMC article. Review.
Cancer vaccines: Targeting KRAS-driven cancers.
Zhang Y, Ma JA, Zhang HX, Jiang YN, Luo WH. Zhang Y, et al. Expert Rev Vaccines. 2020 Feb;19(2):163-173. doi: 10.1080/14760584.2020.1733420. Epub 2020 Mar 14. Expert Rev Vaccines. 2020. PMID: 32174221 Review.
Next batter up! Targeting cancers with KRAS-G12D mutations.
Zeissig MN, Ashwood LM, Kondrashova O, Sutherland KD. Zeissig MN, et al. Trends Cancer. 2023 Nov;9(11):955-967. doi: 10.1016/j.trecan.2023.07.010. Epub 2023 Aug 15. Trends Cancer. 2023. PMID: 37591766 Free article. Review.
Annual review of KRAS inhibitors in 2022.
Wang H, Chi L, Yu F, Dai H, Gao C, Si X, Wang Z, Liu L, Zheng J, Shan L, Liu H, Zhang Q. Wang H, et al. Eur J Med Chem. 2023 Mar 5;249:115124. doi: 10.1016/j.ejmech.2023.115124. Epub 2023 Jan 16. Eur J Med Chem. 2023. PMID: 36680986 Review.
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Kobayashi Y, Chhoeu C, Li J, Price KS, Kiedrowski LA, Hutchins JL, Hardin AI, Wei Z, Hong F, Bahcall M, Gokhale PC, Jänne PA. Kobayashi Y, et al. Nature. 2022 Mar;603(7900):335-342. doi: 10.1038/s41586-022-04451-4. Epub 2022 Mar 2. Nature. 2022. PMID: 35236983
3,132 results